References
- Murali Mohan Babu GV, Prasad CDS, Ramana Murthy KV. (2002). Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine. Int J Pharm, 234:1–17.
- Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, . (2008). In vitro–in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. J Control Release, 130:29–37.
- Waard H, Hinrichs WLJ, Visser MR, Bologna C, Frijlink HW. (2008). Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated. Int J Pharm, 349:66–73.
- Vasconcelos T, Sarmento B, Costa P. (2007). Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today, 12:23–4.
- Jain RA, Brito L, Straub JA, Tessier T, Bernstein H. (2008). Effect of powder processing on performance of fenofibrate formulations. Eur J Pharm Biopharm, 69:727–34.
- Sanganwar GP, Gupta RB. (2008). Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide. Int J Pharm, 360:213–8.
- Wishart DS, Konx C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J. (2006). Drug bank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res, 1:D668-D672.
- Sant VP, Smith D, Leroux JC. (2005). Enhancement of oral bioavailability of poorly water-soluble drugs by poly (ethylene glycol)-block-poly (alkyl acrylate-co-methacrylic acid) self-assemblies. J Control Release, 104:289–300.
- Hanafy A, Spahn-Langguth H, Vergnault G, Grenier P, Tubic Grozdanis M, Lenhardt T, . (2007). Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv Drug Deliv Rev, 59:419–26.
- Vogt M, Kunath K, Dressman JB. (2008). Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: Comparison with commercial preparations. Eur J Pharm Biopharm, 68:283–8.
- Vogt M, Vertzoni M, Kunath K, Reppas C, Dressman JB. (2008). Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs. Eur J Pharm Biopharm, 68:338–45.
- Tan A, Simovic S, Davey AK, Rades T, Prestidge CA. (2009). Silica-lipid hybrid (SLH) microcapsules: A novel oral delivery system for poorly soluble drugs. J Control Release, 134:62–70.
- Huang QP, Wang JX, Zhang ZB, Shen ZG, Chen JF, Yunb J. (2009). Preparation of ultrafine fenofibrate powder by solidification process from emulsion. Int J Pharm, 368:160–4.
- Brodka-Pfeiffer K, Häusler H, Grass P, Langguth P. (2003). Conditioning following powder micronization: Influence on particle growth of salbutamol sulfate. Drug Dev Ind Pharm, 29(10):1077–84.
- Savaşer A, Özkan Y, Işimer A. (2005). Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium. Farmaco, 60:171–7.
- Khan GM, Meidan VM. (2007). Drug release kinetics from tablet matrices based upon ethylcellulose ether-derivatives: A comparison between different formulations. Drug Dev Ind Pharm, 33:627–39.
- Waard H, Hinrichs WLJ, Frijlink HW. (2008). A novel bottom–up process to produce drug nanocrystals: Controlled crystallization during freeze-drying. J Control Release, 128:179–83.
- Mertens B, Cahay B, Klinkenberg R, Streel B. (2008). An automated method for the simultaneous determination of pravastatin, 3-hydroxy isomeric metabolite, pravalactone and fenofibric acid in human plasma by sensitive liquid chromatography combined with diode array and tandem mass spectrometry detection. J Chromatogr A, 1189:493–502.
- Chen YP, Lu Y, Chen JM, Lai J, Sun J, Hu FQ, . (2009). Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Int J Pharm, 376:153–60.
- Takamatsu N, Welage LS, Hayashi Y, Yamamoto R, Barnett JL, Shah VP, . (2002). Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: Correlation with antral gastric motility. Eur J Pharm Biopharm, 53:37–47.
- Plusquellec Y, Efthymiopoulos C, Duthil P, Houin G. (1999). A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption. Med Eng Phys, 21:525–32.